Zavras, P., Wang, Y., Gandhi, A., Lontos, K., & Delgoffe, G. (2019). Evaluating tisagenlecleucel and its potential in the treatment of relapsed or refractory diffuse large B cell lymphoma: Evidence to date. Onco Targets Ther.
Chicago Stili AlıntıZavras, PD, Y. Wang, A. Gandhi, K. Lontos, ve GM Delgoffe. "Evaluating Tisagenlecleucel and Its Potential in the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma: Evidence to Date." Onco Targets Ther 2019.
MLA AlıntıZavras, PD, et al. "Evaluating Tisagenlecleucel and Its Potential in the Treatment of Relapsed or Refractory Diffuse Large B Cell Lymphoma: Evidence to Date." Onco Targets Ther 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..